Category
Primary
cancer · embed-ft 0.75
Tree path
Medical Health › Diseases and Conditions › Cancer
Group (tier-1)
Tech stack
AI readiness
Compliance (GEO / GDPR)
TLD
Overview
Title
ELAHERE (mirvetuximab soravtansine-gynx) treats FRα-positive ovarian cancer
Description
What is ELAHERE? A treatment for people with folate receptor alpha–positive ovarian cancer. Learn more about this targeted therapy.
Final URL
Language
en (html)
Scanned at
2026-06-21 12:44:02